Instituto Universitario de Tecnologías Biomédicas
Instituto de investigación
Universidad de Cantabria
Santander, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Cantabria (27)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
Frontiers in Immunology, Vol. 14
-
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Nature, Vol. 617, Núm. 7962, pp. 764-768
-
HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Hematological Composite Scores in Patients with Inflammatory Bowel Disease
Journal of Clinical Medicine, Vol. 12, Núm. 23
-
Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19
Translational Psychiatry, Vol. 13, Núm. 1
2022
-
Molecular diagnosis in non-small-cell lung cancer: Expert opinion on ALK and ROS1 testing
Journal of Clinical Pathology, Vol. 75, Núm. 3, pp. 145-153
-
Nanoparticle-mediated selective Sfrp-1 silencing enhances bone density in osteoporotic mice
Journal of Nanobiotechnology, Vol. 20, Núm. 1
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Profibrotic Role of Inducible Heat Shock Protein 90α Isoform in Systemic Sclerosis
Journal of immunology (Baltimore, Md. : 1950), Vol. 209, Núm. 1, pp. 38-48
-
Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell
Nefrologia, Vol. 42, Núm. 6, pp. 645-655
2021
-
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer
Oncogene, Vol. 40, Núm. 16, pp. 2923-2935
-
Effective osteogenic priming of mesenchymal stem cells through lna-asos-mediated sfrp1 gene silencing
Pharmaceutics, Vol. 13, Núm. 8
-
Qrisk3 performance in the assessment of cardiovascular risk in patients with inflammatory bowel disease
Journal of Clinical Medicine, Vol. 10, Núm. 18
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Smurf1 Silencing Using a LNA-ASOs/Lipid Nanoparticle System to Promote Bone Regeneration
Stem Cells Translational Medicine, Vol. 8, Núm. 12, pp. 1306-1317
2017
-
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202
-
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3
-
SUMO regulates p21Cip1 intracellular distribution and with p21Cip1 facilitates multiprotein complex formation in the nucleolus upon DNA damage
PLoS ONE, Vol. 12, Núm. 6